Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Retrieved 14 May 2022, from A Phase III, Multicentre, Double-Blind, Randomized, Placebo-Controlled Study to Confirm the Safety and Efficacy of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Erythropoietic Protoporphyria (EPP)
van den Bree MBM, Pickworth WB
6a, TNF supplementation in the media for 8 h induced robust gene expression levels of both c-FLIP and c-IAP, which were significantly downregulated by a 2-h pretreatment with H 2 O 2 , BCNU, or diamide
That makes a clear boundary necessary
US$ 27.86
US$ 27.08
US$ 26.31
US$ 23.77
